Search research articles
Contact Us
Filters
Showing results (21-30 of 104) with videos related to
Page
of 11
Sort By:
Chest
|
January 7, 2011
Omalizumab in asthma: is the therapeutic window too small?
K Deepa Bhat, William J Calhoun
Frontiers in Bioscience (Elite Edition)
|
June 3, 2010
Albuterol enantiomers: pre-clinical and clinical value?
Bill T Ameredes, William J Calhoun
Expert Opinion on Biological Therapy
|
December 6, 2011
Benralizumab--a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity--a novel approach for the treatment of asthma
Aasia Ghazi, Anita Trikha, William J Calhoun
Current Opinion in Pulmonary Medicine
|
December 17, 2008
Biomarkers in asthma
Anandhi Murugan, Curig Prys-Picard, William J Calhoun
Current Allergy and Asthma Reports
|
August 2, 2013
Symptom-based controller therapy: a new paradigm for asthma management
Rohit Divekar, Bill T Ameredes, William J Calhoun
The Journal of Allergy and Clinical Immunology. in Practice
|
November 11, 2019
Forced Oscillometry: A New Tool for Assessing Airway Function-Is It Ready for Prime Time?
Jonathan Ram, Jenny Pineda-Cely, William J Calhoun
Immunology and Allergy Clinics of North America
|
April 4, 2017
Biologic Therapy in Chronic Obstructive Pulmonary Disease
Julia W Tripple, Jennifer L McCracken, William J Calhoun
JAMA
|
January 10, 2013
Strategies for tailoring asthma treatment in adults--reply
William J Calhoun, Homer A Boushey, Bill T Ameredes, et al.
JAMA
|
February 12, 2020
Outpatient Management of Chronic Asthma in 2020
Julia W Tripple, Bill T Ameredes, William J Calhoun
JAMA
|
February 12, 2020
Management of Acute Asthma in Adults in 2020
Mohammed F Zaidan, Bill T Ameredes, William J Calhoun
Page
of 11
Search research articles
Search
Showing results (21-30 of 104) with videos related to
Sort By:
Page
of 11
Chest
|
January 7, 2011
Omalizumab in asthma: is the therapeutic window too small?
K Deepa Bhat, William J Calhoun
Frontiers in Bioscience (Elite Edition)
|
June 3, 2010
Albuterol enantiomers: pre-clinical and clinical value?
Bill T Ameredes, William J Calhoun
Expert Opinion on Biological Therapy
|
December 6, 2011
Benralizumab--a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity--a novel approach for the treatment of asthma
Aasia Ghazi, Anita Trikha, William J Calhoun
Current Opinion in Pulmonary Medicine
|
December 17, 2008
Biomarkers in asthma
Anandhi Murugan, Curig Prys-Picard, William J Calhoun
Current Allergy and Asthma Reports
|
August 2, 2013
Symptom-based controller therapy: a new paradigm for asthma management
Rohit Divekar, Bill T Ameredes, William J Calhoun
The Journal of Allergy and Clinical Immunology. in Practice
|
November 11, 2019
Forced Oscillometry: A New Tool for Assessing Airway Function-Is It Ready for Prime Time?
Jonathan Ram, Jenny Pineda-Cely, William J Calhoun
Immunology and Allergy Clinics of North America
|
April 4, 2017
Biologic Therapy in Chronic Obstructive Pulmonary Disease
Julia W Tripple, Jennifer L McCracken, William J Calhoun
JAMA
|
January 10, 2013
Strategies for tailoring asthma treatment in adults--reply
William J Calhoun, Homer A Boushey, Bill T Ameredes, et al.
JAMA
|
February 12, 2020
Outpatient Management of Chronic Asthma in 2020
Julia W Tripple, Bill T Ameredes, William J Calhoun
JAMA
|
February 12, 2020
Management of Acute Asthma in Adults in 2020
Mohammed F Zaidan, Bill T Ameredes, William J Calhoun
Page
of 11